UNSPSC 42143803: Urodynamic catheters

In this classification, this commodity indicates a product used as a flexible tube inserted through a narrow opening into a body cavity in an artificial insemination procedure. US FDA regulates Urodynamic catheters under 21 CFR 876.1620 and under FDA product code FEN. Most nations, for tariff and trade purposes, schedule these products under HS 901839.

UNSPSC 42143803 Urodynamic catheters is a Commodity code for medical devices used in diagnostic urological procedures, yet the recent state and local opportunities tagged under this code do not reflect urodynamic or medical procurement activity. The three most recent solicitations—Orange County, Florida bridge replacement; City of Brownsville, Texas storm sewer improvements; and Clarendon County, South Carolina drainage pipe removal and replacement—are civil infrastructure projects involving structural engineering, site construction, and drainage systems. State and local procurement offices appear to have misclassified these opportunities, tagging them to a medical device code when the actual work falls under transportation, water management, or construction services. The code shows no relevant recent activity in medical device procurement at the state or local level based on current notice activity.

Given the mismatch between the code's nominal scope and the work actually being solicited, professionals evaluating opportunities under UNSPSC 42143803 should verify the accuracy of code tags in notice abstracts before pursuing qualification or proposal development. The three posted opportunities (bid due July 7, 2026 for Orange County bridge work at $6.2 million; July 14, 2026 for Brownsville stormwater construction; and March 4, 2026 for Clarendon County drainage pipe replacement) represent infrastructure procurement that would properly classify under transportation or construction codes, not medical device taxonomy. Monitor this code for corrections or reclassification by the issuing jurisdictions, or confirm with the procuring offices directly whether future medical device solicitations are anticipated.